Background: In patients with metabolic and nutritional disorders such as diabetes and hyperlipidaemia, where strict compliance to advice on timing and composition of food intake is important, the prolonged daylight fasting during the month of Ramadan could produce undesirable biochemical consequences. Aim: The study aimed to compare pre-and post-Ramadan lipid and lipoprotein pro®les in stable Kuwaiti hyperlipidaemic subjects attending a Lipid Clinic. Subjects and methods: The study population comprised 64 adult Kuwaitis (33 M, 31 F) who had been attending a Lipid Clinic for at least 12 months and were considered stable, without any acute systemic illness. At each clinic visit, the following parameters were measured: weight, total cholesterol (TC), triglycerides (TG), HDL, LDL, apo A-1, apo B, glucose and uric acid. These biochemical parameters were measured by routine automated analyzer techniques. The pre-Ramadan values comprised the means of two measurements taken at about 3 month and 1 month before commencement of Ramadan. Post-Ramadan values were obtained within 1 month of the end of the Ramadan fast. The parameters so obtained were compared in the whole group, and then according to gender, glycaemic status and modality of treatment (diet alone or with a ®brate or statin). Results and discussion: In the nondiabetic subjects, apo A-1 and apo A-1aapo B and apo A-1aHDL ratios were increased post-Ramadan (P`0.001). Weight did not change and the other lipid parameters Ð TC, TG, LDL, apo B Ð did not worsen. These observations, more consistent in the men than in the women, and in subjects treated with a ®brate or a statin rather than on diet alone, indicate a favorable coronary heart disease (CHD) risk pro®le. In the diabetic patients, these changes in the apo A-1 level and its ratio to HDL and apo B were also present, but TC and apo B levels increased, the latter signi®cantly (P`0.05). These divergent effects in diabetic patients could variably in¯uence CHD risk liability. Serum uric acid levels were also simultaneously reduced postRamadan in the non-diabetic subjects and those on statin treatment. Conclusion: When pre-and post-Ramadan lipid and lipoprotein pro®les were compared in stable hyperlipidaemic subjects attending a Lipid Clinic in Kuwait, the most consistent changes post-Ramadan were increased levels of apo A-1 and apo A-1aapo B and apo A-1aHDL ratios and reduced uric acid levels. Body weight remained essentially unchanged and the other lipoprotein and lipid parameters were not worsened. These results suggest that Ramadan fasting in hyperlipidaemic subjects might favorably in¯uence CHD risk.
Introduction
The month of Ramadan is the holiest month in the Islamic calendar. At this time, the faithful abstain from food, drink and conjugal relationships between dawn and dusk. Food and¯uid intake is mainly nocturnal and, generally, food frequency and quantity, sleep duration at night and daily physical activity are reduced. For the healthy, the metabolic changes inherent in this practice do not constitute any signi®cant hazard. In the pregnant and those with metabolic disease, however, there may be undesirable biochemical consequences.
There have been many reports on metabolic changes during and after Ramadan in healthy subjects (Frost & Pirani, 1987; Husain et al, 1987; Finch et al, 1998; Adlouni et al, 1997 Adlouni et al, , 1998 Maislos et al, 1993 Maislos et al, , 1998 el Ati et al, 1995) and in patients with diabetes (Laajam, 1990; Mafauzy et al, 1990; Belkhadir et al, 1993) . In diabetes, assessing such changes is particularly important, since the quantity, quality and timing of meals constitute a most important component of any diabetes management strategy. This is also true of hyperlipidaemia, in which speci®c dietary patterns are prescribed and encouraged typically as part of strategies for primary and secondary coronary heart disease (CHD) prevention. To our knowledge, however, there have been no published reports on biochemical changes related to the Ramadan period in hyperlipidaemic patients on supervised follow-up.
It is currently believed that close to 50% of the adult population in Kuwait and other Gulf Arab countries is hyperlipidaemic (Akanji et al, 1996; Abdella et al, 1998; Mitwalli et al, 1994) . Many attend specialized Lipid Clinics, and we have previously reported on our experience in running such a clinic in Kuwait (Akanji et al, 1996 . Almost all the indigenous population in Kuwait as well as a highly signi®cant proportion of the expatriate population are muslims. Most of these individuals adhere strictly to the Islamic injunction to fast during the holy month of Ramadan. It is therefore of interest to compare pre-and post-Ramadan lipid and lipoprotein pro®les in hyperlipidaemic individuals in Kuwait, relative to the de®nite change in dietary and other habits attendant on Ramadan.
Subjects and Methods

Subjects
Adult Kuwaiti subjects who had been on follow-up at the Lipid Clinic, Mubarak Teaching Hospital, Kuwait for at least 12 months, and considered stable, were invited to participate in the study. They had been diagnosed hyperlipidaemic on the basis of fasting plasma cholesterol (TC) b 7.0 mmolal andaor fasting plasma triglycerides (TG) b 3.0 mmolal andaor current supervised hypolipidaemic medication (Akanji et al, 1996 . All had normal renal, liver and thyroid function and none had any features of CHD. Subjects were classi®ed as diabetic if they were on supervised hypoglycaemic medication or had persistent hyperglycaemia (fasting serum glucose b 7.8 mmolal andaor randoma2 h post 75 g oral glucose value b 11.1 mmolal). None of the recruited subjects was a regular cigarette smoker and none was a habitual alcohol consumer. Indeed, alcohol intake is strictly forbidden in the country. All the subjects undertake the Ramadan fast annually and this study was conducted in the period September 1998 to February 1999, including the period of the Ramadan fast (December 1998 to January 1999).
The recruited subjects were classi®ed on the basis of gender, glycaemic status (diabetic vs non-diabetic), and modality of hypolipidaemic treatment. The latter had been initiated based on their lipid pro®les and risk factors as de®ned by the US NCEP (Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults, 1993; National Cholesterol Education Program, 1989) .
Prior to the Ramadan period, each patient's management had been started with intensi®ed advice on exercise and diet guidelines (National Cholesterol Education Program, 1989) for at least the ®rst 3 months before medication, if indicated, was prescribed. Dietary advice was always given by quali®ed dietitians who typically saw each patient at speci®c intervals in the clinic. This pattern continued during the Ramadan period. The medications used included a statin (lovastatin) for predominant hypercholesterolaemia; a ®brate (beza®brate) for predominant hypertriglyceridaemia and combined statin AE ®brate for mixed hyperlipidaemia and cases of ineffective monotherapy (Hunninghake, 1994 During the period of Ramadan, the subjects fasted daily from 6.00 a.m. to 6.00 p.m. for about a month. The fast was typically broken in the evenings with fruits, especially dates. Thereafter an average of two meals were taken before dawn, according to the clinic dietary guidelines (which were reinforced and emphasized just prior to onset of Ramadan), with varying degrees of compliance. Generally, there was an increased tendency towards intake of more pastries and sweets (simple sugars) and less saturated fat, but total daily caloric intake was generally not increased. However, physical activity was greatly reduced in that the daylight fasting hours were mainly spent resting and praying after daily work. Outings and social visits were essentially nocturnal. The sleep pattern also changed in that most sleep was typically during the daylight hours and not nocturnal.
At clinic follow-up, weight (kg) and blood pressure were measured and laboratory results reviewed. All the subjects gave informed voluntary consent and our institutional Research Ethics Committee approved the procedures.
Laboratory analysis
Overnight fasted blood samples (from the subjects in the morning (07:30 ± 09:00 h) after a 12 ± 14 h overnight fast) would have been collected from each of the study subjects one week prior to clinic review. These samples were analysed for serum lipids and lipoproteins (total cholesterol (TC), triglycerides (TG), HDL), urate, apo A-1 and apo B and plasma glucose according to the following procedure.
Serum was extracted after separation of the blood samples in a refrigerated centrifuge (1800 g, 25 min) within 1 h of specimen collection. The serum samples not analysed immediately were stored frozen at À80 C until analysis, always within 3 months of collection, except for HDL which was always measured from fresh unfrozen samples. The measurements of glucose, TC, TG and urate levels were performed in the Clinical Biochemistry Laboratory of the Mubarak Al Kabeer Hospital, Jabriya, Kuwait, using an Autoanalyser (Hitachi 911, Boehringer Mannheim, Germany) with dedicated reagents obtained from Boehringer Mannheim, Germany. HDL concentrations were determined by an enzymatic cholesterol method on the supernatant obtained after precipitation of the apo B containing particles (LDL and VLDL) by dextran sulphate and Mg (Sigma Diagnostics HDL-cholesterol kit, Sigma Diagnostics, St Louis, MO, USA). The intra-and interassay CVs for our HDL determination were respectively 2.0 and 3.5%. LDL concentrations were subsequently calculated with the formula of Friedewald et al (1972) , for individuals with TG values`4.5 mmolal. The subjects with TG b 4.5 mmolal (n 7) did not have calculated LDL values. The intra-and inter-assay CVs for our LDL determination were both`3.5%. Apo A-1 and B levels were measured in each of the subjects by nephelometry on a Behring Nephelometer Analyzer (Behringwerke AG, Marburg, Germany) using reagents and antibodies also obtained from Behring (Behringwerke AG, Marburg, Germany). For these assays, quality control material (Apolipoprotein Control Serum CHD) obtained from Behring (Behringwerke AG, Marburg, Germany) was derived from reference sera provided by the International Federation of Clinical Chemistry (IFCC) as follows: for apo A-1, IFCC Reference Preparation SP3-07; for apo B, IFCC Reference Preparation SP1-01. The intra-and inter-assay coef®cients of variation (CVs) were 2.2% (apo A-1) and 4.0% (apo B). . With respect to treatment modality, 13 (aged 45.3 AE 14.4 y) maintained satisfactory control on dietary advice alone, 28 (aged 48.9 AE 8.6 y) were treated with a statin and 23 (aged 48.0 AE 10.9 y) received a ®brate. Table 1 indicates the respective anthropometric and biochemical parameters in the whole group before and after Ramadan. Weight was unchanged post-Ramadan. Of the biochemical parameters at this time, apo A-1 and its ratio to total HDL and apo B increased signi®cantly (P`0.001) while uric acid levels fell (P`0.05). Levels of the other lipids and lipoproteins remained essentially unchanged. When data from the whole group was reanalysed according to gender (Table 2) , only apo A-1 changed in the women, increasing signi®cantly post-Ramadan. In the men, apo A-1 and its ratios with HDL and apo B also increased while apo B levels decreased signi®cantly postRamadan, re¯ecting the observations recorded for the whole group. This difference between men and women may be related to the fact that the mean blood glucose levels in the women were much higher than in the men (7.7 AE 3.2 vs 6.0 AE 1.0 mmolal pre-Ramadan and 7.4 AE 3.3 vs 6.1 AE 1.3 mmolal post-Ramadan, both P`0.01). Indeed, about 30% of the female subjects and only about 18% of the males were diabetic. The other parameters remained essentially unchanged.
When the whole group was sub-divided into diabetic (n 15) and non-diabetic (n 49), a similar pattern was again observed (Table 3) . For both the diabetic and nondiabetic, apo A-1 levels increased after Ramadan. However, while TC, apo B and uric acid levels decreased in the non-diabetic subjects, the levels of apo B and TC increased in the diabetic subjects at the same time, the former signi®cantly. Furthermore, the diabetic subjects had increased apo A-1aapo B and apo A-1aHDL ratios, after Ramadan. In the non-diabetic, the apo BaLDL ratio decreased at the same time. The mean glucose values did not change signi®cantly, pre-vs post-Ramadan in both the non-diabetic and diabetic groups.
The biochemical parameters were also compared preand post-Ramadan relative to the treatment modalities adopted for each of the subjects. None of the parameters Ramadan and hyperlipidaemia AO Akanji et al changed post-Ramadan in those subjects managed only with dietary advice. In those actively treated with either a ®brate or a statin however, the apo A-1 level and its ratio with HDL and apo B increased signi®cantly post-Ramadan (all P`0.02). Furthermore, those treated with a statin had reduced uric acid levels post-Ramadan (P`0.05).
Discussion
Most of the reports (Frost & Pirani, 1987; Husain et al, 1987; Finch et al, 1998; Adlouni et al, 1997 Adlouni et al, , 1998 Maislos et al, 1993 Maislos et al, , 1998 el Ati et al, 1995) on the in¯uence of Ramadan fasting on blood lipid and lipoprotein levels have been on healthy volunteers. In studies performed on Ramadan fasting individuals, Frost and Pirani (1987) indicated that a signi®cant increase in caloric, fat, carbohydrate and protein intake during Ramadan resulted in a mean weight gain of about 2 kg. Husain et al (1987) , however, produced contrary results in studies on 21 adult Malaysian muslims undergoing Ramadan fasting, in that there was a postRamadan reduction in body weight consequent on a reduced daily caloric intake. Other studies (Finch et al, 1998; Adlouni et al, 1998) variously demonstrated reduced serum apo B, TC, TG and increased apo A1 and HDL levels with unchangedareduced body weight despite increased caloric intake during Ramadan. In one of these studies, these biochemical changes were maintained for up to a month after Ramadan (Adlouni et al, 1998) . Indeed, Maislos et al (1993 Maislos et al ( , 1998 suggested that the Ramadan model was similar to food gorging, in which a single large evening meal is consumed rather than the more usual pattern of consuming ®ve or six meals at intervals spread over the daylight hours. Their studies on healthy subjects consuming a single evening meal during Ramadan showed consistent increase in HDL (23%) and apo A-1, with decreased TCaHDL and TCaLDL ratios post-Ramadan. TC, TG, LDL, VLDL and Lp(a) levels did not change signi®cantly from pre-Ramadan values. They then concluded that gorging was a desirable non-pharmacological means of increasing HDL levels. In another set of studies exploring this gorging model in hypercholesterolaemic subjects (not undergoing Ramadan fasting), Arnold et al (1994) , found no change in lipid and lipoprotein parameters before and after the subjects consumed three (gorging) or nine (nibbling) meals per day over time.
In this study, the most consistent ®ndings in the nondiabetic hyperlipidaemic subjects were increased apo A-1 and apo A-1aapo B and apo A-1aHDL ratios post-Ramadan in comparison to pre-Ramadan observations. Weight did not change signi®cantly and the other lipid parameters, TC, TG, LDL and apo B, did not worsen. Indeed, TC, LDL and uric acid levels improved somewhat post-Ramadan. These observations were more consistent in the male than in the female subjects and in those subjects treated with a ®brate or a statin (rather than on dietary measures alone). In the diabetic patients, the post-Ramadan bene®cial changes in apo A-1 and its ratio to HDL and apo B seen in the nondiabetic patients were also present. Of some interest, however, was their trend towards increased TC, LDL and apo B levels. These observations are similar to those documented in an earlier report (Laajam, 1990) , and could possibly be related to the rather poor glycaemic control in the study subjects.
The results from this study suggest that the change in dietary habit and frequency during the Ramadan period is probably not deleterious to lipidaemic control in hyperlipidaemic subjects. Body weight and most of the lipid parameters remained unchanged post-Ramadan and, in most of the subjects, there were bene®cial changes in apo A-1 and its ratio to HDL and apo B. It is indeed currently believed that apo A-1 and apo A-1aapo B ratio are better predictors of CHD risk than their respective lipoproteins, HDL and LDL (van Stiphut et al, 1986; Freedman et al, 1986) . These parameters, as determined from this study, would suggest a reduced CHD risk with Ramadan fasting, analogous to the earlier comments on the bene®cial effects of gorging (Maislos et al, 1993 (Maislos et al, , 1998 Arnold et al, 1994) . Further support for this contention derives from the observation of a post-Ramadan reduction in uric acid levels, at least in the non-diabetic subjects and those treated with a statin. Hyperuricaemia is now recognized as a CHD risk factor and any procedure that reduces high uric acid levels should attenuate CHD risk (Coronary Drug Project Research Group, 1976 ).
An intriguing observation in this study is that the fairly consistent post-Ramadan changes in apo A-1 levels were not associated with similar changes in the HDL levels, especially as apo A-1 is the major protein in HDL. However, it has been reported that the correlation coef®cients for the regression lines between apo A-1 and HDL in hyperlipidaemic subjects are not as good as the values reported in normolipidaemic subjects (Austin et al, 1988 , Akanji, 1997 . This may be due to the reported compositional changes in lipoproteins seen not only in hyperlipidaemia. These abnormalities in lipoprotein composition have also been reported in diabetes and impaired glucose tolerance (Contiero et al, 1998 , Pietzsch et al, 1998 , variant angina (Miwa et al, 1998) , high circulating concentrations of nonesteri®ed fatty acids and obesity (Clay et al, 1999) and use of hypolipidaemic medication (Staels & Auwerx, 1998) . Incidentally, about 25% (30% women, 18% men) of our patients were diabetic and about 70% (52% men and 84% women) were obese (BMI b 28.0 kgam 2 ) with 94% (100% women, 88% men) overweight (BMI b 25.0 kgam 2 ). The lack of similar changes in HDL and apo A-1 and the slight differences in patterns of lipoproteins and apolipoproteins between the men and the women in the study could therefore be a re¯ection of these differences in the characteristics of the study population.
Food consumption patterns and dietary habits in the Arabian Gulf have changed in the past decade, due to increasing wealth and Westernization (Musaiger & Miladi, 1995) . The average adult daily calorie consumption is about 3000 kcal, distributed among carbohydrates, fats and proteins but with relatively more increased simple sugars, meat and dairy products. The dietary prescription used for our Lipid Clinic patients is based on the NCEP and AHA guidelines (National Cholesterol Education Program, 1989; Hunninghake, 1994) modi®ed to include locally available foodstuffs. The patients were advised to adhere to these guidelines even during Ramadan. There was however a varying degree of compliance to this dietary advice with generally increased nocturnal feeding often including considerable amounts of simple sugars in dates, cakes, sweets and pastries. It was therefore with some surprise that weight gain was not observed in our patients post-Ramadan. This observation has however been well documented elsewhere (Husain et al, 1987; Finch et al, 1998; Adlouni et al, 1997 Adlouni et al, , 1998 Maislos et al, 1993 Maislos et al, , 1998 el Ati et al, 1995) and is believed due to an increase in fat oxidation during Ramadan, as an adaptive mechanism for body weight maintenance (el Ati et al, 1995) . Another explanation offered is a reported reduced appetite observed in groups of fasting moslems in the UK, especially towards the end of the Ramadan period (Finch et al, 1998 ), but we were unable to document this in our subjects.
It was of some interest to investigate whether the changes we observed in our hyperlipidaemic subjects post-Ramadan fasting were unique, or indeed if they were also present in the other clinic subjects who did not undergo the month-long fast. Follow-up data within the same period was therefore reviewed in 60 other stable patients on follow-up at the Lipid Clinic, with a similar age and sex distribution to the study participants. These were nonmuslims and were therefore not compelled to fast. The results indicated no signi®cant changes in any of the lipid and lipoprotein parameters pre-and post-Ramadan period. Indeed, there was a slight tendency to weight gain in these subjects, which however did not reach statistical signi®-cance (data available with author, but not included in this manuscript). This observation had indeed been reported previously (Akanji et al, 1997) .
Conclusion
When pre-and post-Ramadan lipid and lipoprotein pro®les were compared in stable hyperlipidaemic subjects attending a Lipid Clinic in Kuwait, the most consistent changes were increased apo A-1 levels and ratios of apo A-1aapo B and apo A-1aHDL. Body weight was not increased in spite of the reduced physical activity and reduced compliance to dietary advice attendant on the Ramadan fast. Other lipid parameters were not worsened. These results suggest that Ramadan fasting in stable hyperlipidaemic subjects might favorably in¯uence CHD risk liability.
